Methods of using buffered formulations of exendin (9-39) Grant US-11738086-B2 United States of America 29 Aug 2023
Treatment of post-bariatric hypoglycemia with GLP-1 antagonists Grant US-11622995-B2 United States of America 11 Apr 2023
Treatment of post-bariatric hypoglycemia with exendin (9-39) Grant US-11617782-B2 United States of America 04 Apr 2023
Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives Grant US-11116820-B2 United States of America 14 Sep 2021